WHY IT MATTERS: If federal law changes to restrict hemp-derived THC gummies and similar products, patients currently using them for pain, sleep, or anxiety may need to transition to state-regulated medical cannabis programs or lose access to their current therapies entirely. CLINICAL OVERVIEW: The legal status of THC gummies derived from hemp is under increasing scrutiny as federal lawmakers consider closing the loophole created by the 2018 Farm Bill that allowed hemp-derived THC products to flood the consumer market. From a clinical standpoint, many patients have come to rely on these accessible, legal THC products for symptom management, particularly in states without robust medical cannabis programs.